Smith & Nephew plc – NYSE:SNN

Smith & Nephew stock price today

$36.88
+12.09
+48.77%
Financial Health
0
1
2
3
4
5
6
7
8
9

Smith & Nephew stock price monthly change

-12.71%
month

Smith & Nephew stock price quarterly change

-12.71%
quarter

Smith & Nephew stock price yearly change

-9.46%
year

Smith & Nephew key metrics

Market Cap
10.74B
Enterprise value
13.89B
P/E
71.16
EV/Sales
2.47
EV/EBITDA
13.01
Price/Sales
1.92
Price/Book
4.16
PEG ratio
44.47
EPS
0.91
Revenue
10.86B
EBITDA
2.69B
Income
487.52M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
5.41%
Oper. margin
13.75%
Gross margin
69.04%
EBIT margin
13.75%
EBITDA margin
24.77%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Smith & Nephew stock price history

Smith & Nephew stock forecast

Smith & Nephew financial statements

Average Price Target
Last Year

$27

Potential downside: -26.78%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Smith & Nephew plc (NYSE:SNN): Profit margin
Jul 2022 2.6B 177M 6.81%
Dec 2022 2.74B 48.25M 1.76%
Jul 2023 2.73B 172M 6.29%
Dec 2023 2.79B 90.27M 3.23%
3.02%
Yield TTM
Smith & Nephew plc (NYSE:SNN): Payout ratio
Payout ratio 106.94%
Smith & Nephew plc (NYSE:SNN): Dividend Yield
2019 1.51%
2020 1.78%
2021 2.17%
2022 2.79%
2023 2.75%
Smith & Nephew plc (NYSE:SNN): Debt to assets
Sep 2022 0 4.70B Infinity%
Dec 2022 9966000000 4.70B 47.23%
Jun 2023 9844000000 4.61B 46.84%
Dec 2023 9987000000 4.77B 47.76%
Smith & Nephew plc (NYSE:SNN): Cash Flow
Jul 2022 207M -268M -704M
Dec 2022 282.96M -226.15M -267.33M
Jul 2023 113M -182M -86M
Dec 2023 490.16M -262.43M -112.41M

Smith & Nephew alternative data

Smith & Nephew plc (NYSE:SNN): Employee count
Sep 2023 19,000
Oct 2023 19,000
Nov 2023 19,000
Dec 2023 19,000
Jan 2024 19,000
Feb 2024 19,000
Mar 2024 18,452
Apr 2024 18,452
May 2024 18,452
Jun 2024 18,452
Jul 2024 18,452

Smith & Nephew other data

3.71% -0.95%
of SNN is owned by hedge funds
32.36M -8.54M
shares is hold by hedge funds
Patent
Grant
Filling date: 14 Feb 2020 Issue date: 6 Sep 2022
Grant
Filling date: 13 Sep 2019 Issue date: 30 Aug 2022
Grant
Filling date: 13 Sep 2019 Issue date: 26 Jul 2022
Grant
Filling date: 17 Aug 2018 Issue date: 5 Jul 2022
Grant
Filling date: 15 Mar 2017 Issue date: 21 Jun 2022
Grant
Filling date: 22 Dec 2016 Issue date: 21 Jun 2022
Grant
Filling date: 20 May 2020 Issue date: 14 Jun 2022
Grant
Filling date: 29 Jul 2019 Issue date: 14 Jun 2022
Grant
Filling date: 29 Mar 2018 Issue date: 7 Jun 2022
Grant
Filling date: 1 Feb 2019 Issue date: 31 May 2022
Insider Compensation
Mr. Roland D. Diggelmann (1967) Chief Executive Officer & Director $1,700,000
Ms. Anne-Francoise Nesmes (1972) Chief Financial Officer & Executive Director
$799,640
Friday, 20 December 2024
zacks.com
Thursday, 19 December 2024
globenewswire.com
Tuesday, 17 December 2024
zacks.com
Monday, 16 December 2024
globenewswire.com
Tuesday, 3 December 2024
proactiveinvestors.co.uk
Thursday, 14 November 2024
reuters.com
Sunday, 10 November 2024
seekingalpha.com
Saturday, 2 November 2024
seekingalpha.com
Thursday, 31 October 2024
proactiveinvestors.co.uk
reuters.com
Wednesday, 16 October 2024
globenewswire.com
Tuesday, 15 October 2024
zacks.com
Friday, 11 October 2024
zacks.com
Wednesday, 9 October 2024
globenewswire.com
Friday, 20 September 2024
zacks.com
Wednesday, 18 September 2024
youtube.com
globenewswire.com
Friday, 13 September 2024
zacks.com
Tuesday, 10 September 2024
globenewswire.com
Wednesday, 21 August 2024
seekingalpha.com
Monday, 12 August 2024
zacks.com
Wednesday, 7 August 2024
zacks.com
Thursday, 1 August 2024
proactiveinvestors.co.uk
reuters.com
Wednesday, 24 July 2024
zacks.com
Wednesday, 17 July 2024
zacks.com
Saturday, 13 July 2024
cnbc.com
Monday, 8 July 2024
zacks.com
Friday, 5 July 2024
benzinga.com
Thursday, 4 July 2024
marketwatch.com
  • What's the price of Smith & Nephew stock today?

    One share of Smith & Nephew stock can currently be purchased for approximately $36.88.

  • When is Smith & Nephew's next earnings date?

    Unfortunately, Smith & Nephew's (SNN) next earnings date is currently unknown.

  • Does Smith & Nephew pay dividends?

    Yes, Smith & Nephew pays dividends and its trailing 12-month yield is 3.03% with 107% payout ratio.It means that the company is paying a dividend greater than earnings. The last Smith & Nephew stock dividend of $0.28 was paid on 27 Oct 2021.

  • How much money does Smith & Nephew make?

    Smith & Nephew has a market capitalization of 10.74B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.4% to 5.55B US dollars.

  • What is Smith & Nephew's stock symbol?

    Smith & Nephew plc is traded on the NYSE under the ticker symbol "SNN".

  • What is Smith & Nephew's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Smith & Nephew?

    Shares of Smith & Nephew can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Smith & Nephew's key executives?

    Smith & Nephew's management team includes the following people:

    • Mr. Roland D. Diggelmann Chief Executive Officer & Director(age: 58, pay: $1,700,000)
    • Ms. Anne-Francoise Nesmes Chief Financial Officer & Executive Director(age: 53, pay: $799,640)
  • How many employees does Smith & Nephew have?

    As Jul 2024, Smith & Nephew employs 18,452 workers.

  • When Smith & Nephew went public?

    Smith & Nephew plc is publicly traded company for more then 25 years since IPO on 16 Nov 1999.

  • What is Smith & Nephew's official website?

    The official website for Smith & Nephew is smith-nephew.com.

  • How can i contact Smith & Nephew?

    Smith & Nephew can be reached via phone at +44 1923 477100.

  • What is Smith & Nephew stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for Smith & Nephew in the last 12 months, the avarage price target is $27. The average price target represents a -26.78% change from the last price of $36.88.

Smith & Nephew company profile:

Smith & Nephew plc

smith-nephew.com
Exchange:

NYSE

Full time employees:

18,000

Industry:

Medical - Devices

Sector:

Healthcare

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Building 5
Watford, WD18 8YE

CIK: 0000845982
ISIN: US83175M2052
CUSIP: 83175M205